Brainomix, an Oxford-born company pioneering AI-powered imaging tools in stroke and lung fibrosis, has clinched an $18 ...

Aura Biosciences (NASDAQ:AURA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a ...

An Oxford University spinout has secured £14 million in funding to advance its "transformative" AI imaging technology in healthcare.

In a report released today, Sam Slutsky from LifeSci Capital maintained a Hold rating on InflaRx (IFRX – Research Report). The company’s shares ...

Proscia sells digital pathology software and artificial intelligence tools to pharmaceutical companies and diagnostic ...

Brainomix has developed Brainomix 360 Stroke, an AI-powered platform that analyses medical images to support stroke diagnosis and treatment.

Brainomix, a company pioneering AI-powered imaging tools in stroke and lung fibrosis, today announced the completion of a ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

LifeSci Capital analyst Charles Zhu initiated coverage with a Buy rating on Zymeworks (ZYME – Research Report) today and set a price target of ...

Investment analysts at Lifesci Capital boosted their FY2025 EPS estimates for Dianthus Therapeutics in a research note issued to investors on Wednesday, March 12th. Lifesci Capital analyst R. Katkhuda ...